B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?

Lancet Rheumatol. 2020 Oct;2(10):e589-e590. doi: 10.1016/S2665-9913(20)30270-8. Epub 2020 Jul 31.

Authors

Puja Mehta^{1

2}, Joanna C Porter¹, Rachel C Chambers¹, David A Isenberg², Venkat Reddy²

Affiliations

¹ Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, London, UK.
² Department of Rheumatology, University College London Hospital, London NW1 2PG, UK.

No abstract available

Grants and funding